Assignment of Assignor's Interest

Recorded: 2015-11-03 Received: 2015-11-03 Pages: 18

Assignor

NOVARTIS AG

Executed: 2015-07-28

Assignee

NOVARTIS PHARMA AG

POSTFACH, BASEL, CHX, 4002, SWITZERLAND

Covered Properties (10)

Use of a Pyrazole Derivative in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Application: 14/386,174 →

Pharmaceutical Compositions Comprising an Aromatse Inhibitors

Application: 14/342,813 →

Use of an Aromatase Inhibitor for the Treatment of Hypogonadism and Related Diseases

Application: 14/342,810 →

5-Membered Heterocycle-Based P38 Kinase Inhibitors

Application: 13/775,963 →

Polynucleotides Encoding Antibodies Against Sclerostin and Uses Therefor

Application: 13/547,598 →

5-Membered Heterocycle-Based P38 Kinase Inhibitors

Application: 13/530,919 →

5-Membered Heterocycle-Based P38 Kinase Inhibitors

Application: 12/950,649 →

Compositions and Methods for Use for Antibodies Against Sclerostin

Application: 12/944,019 →

Compositions and Methods for Use for Antibodies Against Sclerostin

Application: 12/249,050 →

5-Membered Heterocycle-Based P38 Kinase Inhibitors

Application: 10/877,534 →